In summary, discovery of a T cell epigenetic clock that is uncoupled from proliferative decline highlights T cell aging metrics that are distinct from the properties that limit somatic cell lifespan and provide a hallmark for assessing cancer-free T cell aging. The gene discussed is CLOCK; the disease is cancer.